ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Hyloris Pharmaceuticals SA

Hyloris Pharmaceuticals SA (HYL)

6.24
-0.50
(-7.42%)
Closed March 24 12:30PM

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20172017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 0213k91k91k175k3.1M2.39M4.21M
Operating Income 0-3.87M-5.47M-5.27M-7.05M-10.54M-11.64M-15.99M
Pre Tax Income 0-3.78M-6.06M-5.78M-7.14M-11.28M-11.9M-15.38M
Net Income 0-3.72M-5.79M-5.37M-7.15M-11.58M-11.91M-15.38M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0-1.267-1.713-1.207-0.277-0.448-0.425-0.549
EBIT 0-3.87M-5.47M-5.27M-7.02M-10.54M-11.64M-15.99M
EBITDA 0-3.8M-5.38M-1.97M-6.46M-10.41M-11.44M-15.65M